Profil
Mr. Neil S.
Belloff was previously employed as a Secretary & General Counsel by Acorda Therapeutics, Inc., a COO, Secretary, EVP & General Counsel by Eloxx Pharmaceuticals, Inc., a Senior Corporate Counsel by Celgene Corp., and an Executive VP, US Corporate & Securities Counsel by Deutsche Telekom AG.
He received his undergraduate degree from Queens College, a graduate degree from New York University and a graduate degree from Quinnipiac University School of Law.
Ehemalige bekannte Positionen von Neil Belloff
| Unternehmen | Position | Ende |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | General Counsel | 21.08.2024 |
| ELOXX PHARMACEUTICALS, INC. | Geschäftsführer | 25.08.2021 |
| CELGENE | Corporate Officer/Principal | - |
| DEUTSCHE TELEKOM AG | Corporate Officer/Principal | - |
Ausbildung von Neil Belloff
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Deutsche Telekom AG
Deutsche Telekom AG Major TelecommunicationsCommunications Provides telecommunication services | Communications |
Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops neurology therapies | Health Technology |
Queens College
Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quinnipiac University School of Law
Quinnipiac University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
















